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Abstract n-aspartate and human ehorionic gonadotropin act 
synergistically to increase testosterone production in purified rat 
Leydig cells, and n-aspartate stimulates testosterone synthesis 
even in the absence of human chorionic gonadotropin stimulation. 
In addition, D-aspartate enhances teady-state cellular mRNA 
and protein levels of steroidogenic acute regulatory protein, 
which is a key regulatory factor in gonadal and adrenal 
steroidogenesis, n-aspartate therefore appears to increase 
testosterone production in rat Leydig cells by stimulating 
steroidogenic acute regulatory protein gene expression. To our 
knowledge, this is the first report demonstrating a direct effect of 
D-aspartate on gene expression in mammalian cells. 
© 1999 Federation of European Biochemical Societies. 
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1. Introduction 
The presence of D-aspartate (D-Asp) has been demonstrated 
in a wide variety of mammalian tissues [1,2]. Levels of this 
unique amino acid are transiently increased uring tissue de- 
velopment [1,2]. We recently demonstrated that D-Asp is lo- 
calized in specific cell types in developing tissues [3-5] and 
changes its localization within the organs as well as its intra- 
cellular distribution during development [6]. Our recent study 
also indicated that D-Asp is actually synthesized in mamma- 
lian cells [7]. These results suggested that D-Asp has some 
physiological functions in mammalian cells. Indeed, D-Asp 
suppresses norepinephrine-induced m latonin secretion in cul- 
tured rat pinealocytes, which contain significant levels of the 
amino acid in vivo [8]. 
In adult rat testis, approximately 30% of the total Asp 
content is in the D-form [3,9]. Our previous report demon- 
strated that D-Asp increases human chorionic gonadotropin 
(hCG)-induced testosterone production in purified rat Leydig 
cells [10]. In these cells, intracellular cholesterol is transported 
to the inner mitochondrial membrane, where cholesterol is 
converted to pregnenolone by cytochrome P450 side-chain 
cleavage (P450scc) as the first step in testosterone synthesis. 
The process of cholesterol delivery to the inner mitochondrial 
membrane is the rate-limiting step for testosterone synthesis, 
which is activated in response to hCG stimulation by a cAMP 
signal transduction pathway [11,12]. D-Asp increases testos- 
terone production without affecting the cAMP content of the 
cells, and its point of action was traced to the rate-limiting 
process of cholesterol delivery. L-Asp, D,L-glutamate and D,L- 
asparagine were all unable to substitute for D-Asp, which is 
presumably to be taken up into the cells to increase steroid 
hormone production [10]. 
Steroidogenic acute regulatory protein (STAR) is a key reg- 
ulatory protein which plays an essential role in gonadal and 
adrenal steroidogenesis. It is assumed to enhance the rate- 
limiting step, cholesterol delivery to the inner mitochondrial 
membrane [11,13]. Mutations in the StAR gene are responsi- 
ble for congenital lipoid adrenal hyperplasia, an autosomal 
recessive disease in which adrenal and gonadal steroid syn- 
thesis is markedly impaired [14]. StAR mRNA is specifically 
expressed in steroidogenic tissues uch as the testis, ovary and 
adrenal gland [15,16]. In these tissues, StAR expression is 
stimulated by trophic hormones uch as adrenocorticotropic 
hormone, luteinizing hormone and follicle-stimulating hor- 
mone [12]. Transfection of steroidogenic and non-steroidogen- 
ic cells with StAR cDNA directly increased steroid production 
in the absence of hormone stimulation [17,18]. 
In this report, we demonstrate hat D-Asp and hCG act 
synergistically to increase testosterone production in purified 
rat Leydig cells, and that D-Asp stimulates testosterone syn- 
thesis even in the absence of hCG stimulation. Furthermore, 
D-Asp enhances steady-state levels of StAR mRNA and pro- 
tein. D-Asp therefore appears to increase testosterone produc- 
tion by stimulating StAR gene expression i  rat Leydig cells. 
To our knowledge, this is the first report demonstrating an 
effect of D-Asp at the genetic level in mammalian cells. 
2. Materials and methods 
2.1. Materials 
hCG and D-Asp were obtained from Sigma Chemical Co. (St. 
Louis, MO, USA). [c~-32p]-dCTP (110 TBq/mmol) was a product of 
Amersham Pharmacia Biotech Inc. (Piscataway, NJ, USA). Oligonu- 
cleotide primers were prepared by Sawady Technology Inc. (Tokyo, 
Japan). Restriction enzymes and Taq DNA polymerase were pur- 
chased from TAKARA (Kyoto, Japan). Horseradish peroxidase-con- 
jugated goat anti-rabbit IgG was a product of Seikagaku Corporation 
(Tokyo, Japan). 
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2.2. Rat Leydig cell preparation and culture 
Rat Leydig cells were prepared and cultured as described previously 
[10]. The purified Leydig cells were cultured in the presence orabsence 
of 200 gM D-Asp for 16 h, followed by incubation with varying 
concentrations of hCG for 2 h before being removed from the culture 
media by centrifugation at600 × g. The media were then assayed for 
testosterone content. 
0014-5793/99/$20.00 © 1999 Federation of European Biochemical Societies. All rights reserved. 
PII: S00 1 4-5793(99)00840-6  
318 K Nagata et al./FEBS Letters 454 (1999) 31~320 
2.3. En: 3'me imnnmoassay (EIA) qf testosterone 
Testosterone in the culture media was measured by enzyme immu- 
noassay as described previously [10]. 
2.4. Preparation o/' StAR probe 
A 224 bp rat StAR cDNA fragment was amplified by PCR using 
primers (sense: AACACTCTACAGTGACCAGGAGCTGT, anti- 
sense: GGTCCACCAGTTCTTCATAG) which correspond to the 
rat StAR cDNA sequences nt192-217 and nt415 396 [19] and cloned 
into a pT7Blue-2 T-vector (Novagen, Madison, WI, USA). The re- 
sulting insert was extracted and purified using a QIAEX II kit (QIA- 
GEN Inc., Valencia, CA, USA), and labeled with 1.85 MBq of 
[(x-32P]-dCTP (109 dpm/~g) using a DNA labeling kit (Ready To Go, 
Amersham Pharmacia Biotech), according to the respective manufac- 
turers' instructions. Labeled probes were separated from free nucleo- 
tides with G50 spin columns (ProbeQuant, Amersham Pharmacia 
Biotech). 
2.5. RNA extraction and Northern blot analysis 
Total RNA was extracted from cultured rat Leydig cells with 1SO- 
GEN reagent (Wako Chemical Ind., Osaka, Japan), a mono-phasic 
solution of phenol and guanidine isothiocyanate. Approximately 30 
~tg of total RNA was separated by electrophoresis on 1.0% agarose/ 
18% formaldehyde/MOPS gels and transferred to Hybond N- nitro- 
cellulose membranes (Amersham Pharmacia Biotech). After 1 h of 
prehybridization at 65°C, filters were hybridized with the labeled 
probes (rat StAR probe or rat glyceraldehyde-3-phosphate dehydro- 
genase (G3PDH) cDNA) at 1 2x 106 dpm/cm 2 for 2 h at 65°C in 
hybridization buffer (Rapid hyb buffer, Amersham Pharmacia Bio- 
tech). Following hybridization, membranes were rinsed with 2 × SSPE, 
0.1% SDS and washed in 0.1 × SSPE, 0.1% SDS and then exposed to 
Kodak X-OMAT AR films at -80°C for 1 2 days. Intensities of 
autoradiographic bands were estimated by densitometric s anning. 
2.6. Western blot analysLs" 
Cultured Leydig cells were solubilized in the well with 0.1% SDS 
and cellular proteins were separated on 12.5% SDS/polyacrylamide 
gels and electrophoretically transferred to nitrocellulose membranes. 
The membranes were incubated for 1 h at room temperature (R.T.) 
with a rabbit polyclonal antibody raised against a ten amino acid 
peptide containing residues #88-98 of the 30 kD StAR protein [18]. 
The antibody was kindly donated by Prof. D.M. Stocco, Texas Tech 
University, TX, USA. Subsequently the membranes were incubated 
with horseradish peroxidase-conjugated goat anti-rabbit IgG for 1 h 
at R.T. and bound antibody was detected by chemiluminescence using 
a ECL detection kit (Amersham Pharmacia Biotech) and Kodak X- 
OMAT AR films. 
2. 7. Statistical analj'sis 
Results were expressed as mean+standard deviation. Significant 
differences between groups were determined by Duncan's multiple- 
range test. 
3. Results 
3.1. D-Asp effect on testosterone synthesis in rat Leydig cells 
In a previous report [10], we demonstrated that D-Asp in- 
creases hCG-induced testosterone synthesis in a dose-depend- 
ent manner  in purified rat Leydig cells. In the present study, 
we examined the effect of D-Asp on the testosterone synthesis 
induced by varying doses of hCG. D-Asp (200 ~JM) stimulated 
testosterone production to a similar extent in cells exposed to 
a wide range of hCG concentrations (Fig. I A). D-Asp and 
hCG therefore appear to have synergistic rather than additive 
effects on testosterone synthesis. In addition. D-Asp but not 
L-Asp stimulated testosterone product ion even in the absence 
of hCG stimulation (Fig. 1B). The increase in testosterone 
synthesis was observed in cells treated with D-Asp for 16 h 
but not in cells treated for 1 h (Fig. 1B). The effect of D-Asp 
on hCG-induced testosterone synthesis was also time-depend- 
ent and required more than 3 h exposure to D-Asp to become 
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Fig. 1. D-Asp effect on testosterone synthesis in rat Leydig cells. A: 
Purified rat Leydig cells were cultured for 16 h in the presence or 
absence of 200 ~aM D-Asp and then incubated with the indicated 
concentrations of hCG for 2 h before testosterone s creted into the 
medium was assayed by EIA. Data are shown as mean + S.D., n = 3. 
B: Purified Leydig cells were cultured for the indicated time periods 
in the presence or absence of 200 ~JM D- or L-Asp and then incu- 
bated for 2 h without stimulation by hCG before testosterone s - 
creted into the medium during this incubation was assayed by EIA. 
Results which are significantly different from controls are indicated 
by asterisks (P < 0.01, n = 3). 
apparent [10]. These lines of evidence suggest hat D-Asp acts 
at a site(s) distinct from the stimulatory pathway activated by 
hCG. 
3.2. D-A~T effect on S tAR gene expression in rat Leydig cells 
We previously demonstrated that D-Asp is taken up into 
rat Leydig cells to increase the rate of cholesterol transport  o 
the inner mitochondrial  membrane [10]. Cytochrome P450 
side-chain cleavage (P450scc) at this site catalyzes the first 
step in steroid hormone synthesis. The process of transloca- 
tion to the inner mitochondrial  membrane is the rate-limiting 
step for steroid synthesis, and StAR is the key regulatory 
protein in this process [11,13]. 
Fig. 2 demonstrates that D-Asp increases hCG-induced 
StAR gene expression in rat Leydig cells, hCG induces 
StAR expression by increasing transcription of the gene 
through a cAMP second messenger pathway [20,21]. Northern 
blot analysis demonstrated that the steady-state l vel of StAR 
mRNA is increased by hCG treatment, and prior treatment 
with D-Asp further increased the StAR mRNA level approx- 
imately 3.5-fold relative to hCG treatment without D-Asp. 
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Fig. 2. Northern blot analysis. Purified Leydig ceils were cultured 
for 16 h in the presence or absence of 200 btM D-Asp and then 
stimulated with 5 mlU/ml hCG or incubated without hCG. Total 
RNA (30 gg) was prepared from the cells, separated on formalde- 
hyde-denaturing gels and transferred to nylon membranes. Blots 
were hybridized with [32p]-labeled rat StAR and G3PDH DNA 
probes. Lower panel: Representative Northern blot. Two major 
transcripts (3.8 and 1.7 kb) [26] are evident. Upper panel: The in- 
tensities of the autoradiographic bands were estimated and ex- 
pressed as StAR/G3PDH ratios. The data presented relate to the 
3.8 kb transcript and are shown asmean + S.D. (n = 6). 
Moreover, StAR mRNA levels were also increased by D-Asp 
treatment even in the absence of hCG stimulation (data not 
shown). 
In Fig. 3, Western blot analysis was carried out using total 
protein from the Leydig cells. The protein levels detected by 
anti-StAR antibody were increased significantly by hCG stim- 
ulation, and D-Asp pretreatment further increased the protein 
level approximately 1.9-fold. These lines of evidence indicate 
that D-Asp enhances StAR gene expression at both mRNA 
and protein levels, resulting in the increased production of 
testosterone in rat Leydig cells. 
STAR, and the induced StAR protein is assumed to facilitate 
by as yet undefined mechanism the translocation of cholester- 
ol to the inner mitochondrial membrane, which is a rate-limit- 
ing process in steroid synthesis [13]. We have previously dem- 
onstrated that D-Asp increases hCG-induced testosterone 
production without affecting cAMP levels [10]. Because D- 
Asp increases dibutyryl cAMP-induced testosterone synthesis, 
but does not affect steroid synthesis after 22(R)-hydroxychol- 
esterol supply, it appears that D-Asp acts primarily on the 
process of cholesterol translocation to the inner mitochondrial 
membrane [10]. The present results are consistent with these 
earlier observations. 
The molecular mechanism of D-Asp stimulation of StAR 
gene expression is still unclear at present. Whether the in- 
crease in StAR mRNA levels is due to enhanced transcription, 
increased message stability or both, remains to be elucidated. 
In the previous report [10] it was shown that D-Asp should be 
taken up into Leydig cells for the stimulation of steroidogen- 
esis. Uptake of D-Asp through the c-glutamate transporter is 
known to induce several changes in cells, including intracel- 
lular acidification [22] and activation of Cl conductance [23], 
which may play a role in the increased StAR expression. Al- 
ternatively, a specific factor(s) may interact with D-Asp and 
cause the observed stimulation of StAR gene expression. 
Moreover, phosphorylation can enhance StAR activity [24] 
and D-Asp may have an effect on StAR phosphorylation i  
addition to its effect on StAR gene expression. 
There is some discrepancy between the magnitude of the D- 
Asp effects on StAR mRNA (Fig. 2) and StAR protein (Fig. 
3). StAR protein is synthesized as a large precursor including 
an N-terminal mitochondrial t rgeting sequence, and is sub- 
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4. Discussion hCG - + + 
This study demonstrated that D-Asp and hCG synergisti- 
cally up-regulate the production of testosterone in rat Leydig 
cells, apparently by increasing StAR gene expression. D-Asp 
alone increases testosterone production and enhances StAR 
expression, even in the absence of hCG stimulation. To our 
knowledge, this is the first report of a direct effect of D-Asp 
on mammalian gene expression. 
In Leydig cells, hCG increases testosterone production via 
activation of adenylate cyclase [12]. The increased levels of 
cAMP up-regulate several steroidogenic genes, including 
D-Asp - - + 
Fig. 3. Western blot analysis. Total cell homogenate (5 btg protein) 
was prepared from rat Leydig cells precultured in the presence or 
absence of 200 btM D-Asp for 16 h before being incubated with 
5 mIU/ml hCG or without hCG for 2 h. Proteins were separated on 
12.5% SDS/polyacrylamide gels and transferred to nitrocellulose 
membranes. Blots were probed with polyclonal antibody against 
StAR and bound antibody was detected by ECL. Lower panel: 
StAR protein with a molecular mass of approximately 30 kDa was 
detected [26]. Upper panel: The intensities of the bands were esti- 
mated and compared. The data are shown as mean_+ S.D. (n = 3). 
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sequently imported by the mitochondria with concomitant 
cleavage of the N-terminal peptide resulting in appearance 
of the mature form [13]. However, mitochondrial importation 
is not required for StAR activity, since N-terminal deletion 
mutants of StAR have activities equivalent o that of wild- 
type StAR [17]. It is believed that the StAR precursor, not the 
mature form, is the form which is active outside the mitochon- 
dria and increases the rate of cholesterol translocation, possi- 
bly acting as a cholesterol transfer protein [25]. The mature 
form, which we detected in this study by Western blot, is 
thought to have no action on cholesterol transfer. StAR pre- 
cursor protein was not detected in the present study, probably 
because it is much more labile than the mature form [17]. The 
apparent discrepancy between the increases in mRNA and 
protein levels of the mature form may be due to the labile 
nature of the precursor form. Similar discrepancies have been 
reported elsewhere [26,27]. 
Approximately 30% of total Asp is in the D-form in the rat 
testis [3,9]. D-Asp is mainly localized in the cytoplasm of 
elongate spermatids, the most mature of the germ cells, and 
is assumed to regulate steroidogenesis a a paracrine factor in 
the testis [3]. D-Asp is also present in other steroidogenic 
tissues such as the ovary, adrenal cortex and brain [1,28], 
where the levels of D-Asp are developmentally and spatially 
regulated [1,3,6]. Our results indicate that D-Asp may regulate 
steroid production through modulation of StAR gene expres- 
sion in these steroidogenic tissues. Furthermore, D-Asp may 
play other, as yet undefined roles in other D-Asp-containing 
organs such as the pituitary, pineal gland and adrenal medul- 
la, possibly by regulating the expression of genes other than 
STAR. The observations in this report should contribute to 
our understanding of the physiological functions of D-Asp 
in mammals. 
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